Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|NSCLC|Ovary Cancer|Endometrial Cancer|Small Cell Lung Cancer (SCLC)|Head and Neck (HNSCC)
Interventions: DRUG: PF-05212384|DRUG: Paclitaxel|DRUG: Carboplatin
Sponsor: Cristiana Sessa